Sciele Pharma News
Most Popular Sciele Pharma Story
ALSO NOTED: Cephalon touts Fentora data; Northfield pursuing PolyHeme approval; FDA accepts NDA; and much more...
> Cephalon is reporting positive results from a study on its pain drug Fentora in non-cancer related pain. Read more...
Latest Headlines
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
